The global hpv vaccines market size was valued at USD 4,867.9 million in 2021 and is poised to grow at a CAGR of 5.3% during the forecast period by 2022-2028. due to growing prevalence of myopia across the globe. HPV vaccines protect against infection with human papillomaviruses (HPV). HPV is a group of more than 200 related viruses, of which more than 40 are spread through direct sexual contact. Among these, two HPV types cause genital warts, and about a dozen HPV types can cause certain types of cancer—cervical, anal, oropharyngeal, penile, vulvar, and vaginal. Three vaccines that prevent infection with disease-causing HPV types are licensed for use in the United States: Gardasil®, Gardasil® 9, and Cervarix®.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/hpv-vaccines-market/      

 

The global hpv vaccines market segmentation:

1) By Product Type: Bivalent, Polyvalent, Others.

2) By Disease Indication: HPV Associated Cancer, Genital Warts, Others.

3) End User: Hospitals & Retail Pharmacies, Government Suppliers, Others.

Genital Warts Accounted for Higher Revenue Share in Global HPV Vaccines Market:

Based on disease indication, global HPV vaccines market is segmented into HPV associated cancer, genital warts, other. Genital Warts is accounted for higher revenue.  Genital warts are a common sexually transmitted infection caused by the human papillomavirus (HPV). The characteristic symptom is a small bump on the genitals. Vaccines can protect against many genital-wart-causing strains of HPV. Genital warts can be treated with prescription medication applied directly to the warts or can be surgically removed. Sexual health clinics are sometimes called genitourinary medicine (GUM) clinics, or sexual and reproductive health (SRH) services.

North America leads the Global HPV Vaccines Market:

Based on regional analysis, global HPV vaccines market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America global HPV vaccines market contributed the largest share in 2021. This is due to the availability of well-established healthcare systems, combined with the ease of access to the resources required. In addition, individuals are well conscious of the presence of vaccines and other treatment processes. The increase in vaccination and treatment choice at the nearest healthcare institution would also add traction to the growth of the regional sector.

Strategic Acquisitions, Merger, Agreements, Collaborations and Partnerships are the key strategies adopted by market players:

Global HPV vaccines market further reveals that the key player’s increasingly adopting strategies such as strategic acquisitions, merger, agreements, collaborations and partnerships to enhance market revenue share. For instance, September 2019 – China-based ‘Xiamen Innovax Biotech’ and GlaxoSmithKline signed a collaborative agreement for manufacturing and marketing of the next-generation HPV vaccines. March 2019 – The government of Maldives engaged in a joint venture with World Health Organization for the launch of human papillomavirus immunization for girls between the ages 10 to 14 years.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=58976        

Key player’s profiles in the global HPV Vaccines market are: GlaxoSmithKline plc., Merck & Co., Inc, Johnson & Johnson, Serum Institute of India Pvt. Ltd., Sanofi S.A.

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and produce high-quality research reports. We have over five hundred clients with a good business partnership the capacity to provide in-depth research analysis for more than thirty countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and our services.

 

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747